Imperial College London
Molecular and Translational Haematology BSc
The BSc in Molecular and Translational Haematology focuses on the physiology of the the blood and the pathophysiology of blood-related disorders.
The intercalated BSc programmes at Imperial aim to develop the next generation of clinicians and academics with the ability to interpret the scientific literature, informing your practice in understanding and treating a wide array of blood-related disorders.
The 1-year course comprises a core teaching module, an independent learning and group assessment module, and a 14-week research project.
The course is delivered as a distinctive programme that enhances your understanding through immersion in these environments. The programme will explore the physiology of the bone marrow and a wide range of malignancies and disorders associated with bone marrow derived cells. The course will also explore how different bleeding and thrombotic disorders are manifest and treated
Aims and Objectives
By the end of the course, students will be able to:
• Critically appraise a wide variety of academic literature and understand the importance of applying research skills in clinical medicine.
• Explain how haematological malignancies can be manifest and treated.
• Discuss the challenges and considerations associated with therapeutic options for blood-related disorders
• Understand the importance of scientific understanding in guiding clinical practice
• Confidently present scientific information to different audiences, through various communication methods
Module 1 – The Taught Module
Module 1 is a 12-week teaching block. It takes you through the key areas of:
• The bone marrow niche
• Haematological malignancies
• New and emerging therapeutics, including small molecule inhibitors, CAR T cell therapy, transplantation, immunotherapies and gene therapy
• This is delivered through a combination of lectures, workshops, journal clubs, group work, and self-guided learning.
Module 2 – Self-Directed Learning
Module 2 is a 5-week block. In Module 2, you will apply knowledge you gain to clinical scenarios, exploring the evidence behind new clinical presentations and concepts introduced in module 1. You will also complete a group writing task, reviewing the evidence in an area from the course.
Module 3 – Research Project
Module 3 uses the skills learnt in Modules 1 and 2 to carry out a novel 14-week project – either clinical or lab-based – in a haematology-related discipline.
Entry requirements
This is a one-year intercalated BSc. To be eligible to apply you must:
• Be registered on a recognised Medical, Dental or Veterinary course at a UK or Irish university.
• Have completed at least one year of that course before you apply to Imperial. i.e. you must be at least in Year 2 in 2023/24.
• Have at least one year of your degree left when you return to your home institution after completing your intercalated BSc.
Application Process
Admissions for 2024-25 entry are now open. The application deadline will be 16:00 on Friday 1 March 2024.
Selection is based on your application form and the supporting documents you will upload with your application. Please find further information about the application process on our website.
The BSc in Molecular and Translational Haematology will run from Monday 23 September 2024 until Friday 16 May 2025.
If you have any queries about the application process, please email the Faculty Education Office (BSc Team) at feo.bsc@imperial.ac.uk.
Second Round of Applications
Unsuccessful or wait-listed applicants will be given the opportunity to make a second application to any BSc course with space remaining.
Closing date
16:00 on Friday 1 March 2024.